Advertisement
Screener

REPLIMUNE GROUP, INC. (REPL) ROA

REPLIMUNE GROUP, INC. (REPL) ROA

  • 2026-06-30: ROA -117.65%.
  • 2026-03-31: ROA -94.45%.
  • 2025-12-31: ROA -94.38%.
  • 2025-09-30: ROA -79.67%.

Complete source-backed roa history.

Available history
2018-03-31 to 2026-06-30
Data captured

Historical ROA

DateROA
2026-06-30-117.65%
2026-03-31-94.45%
2025-12-31-94.38%
2025-09-30-79.67%
2025-06-30-59.68%
2025-03-31-44.85%
2024-12-31-37.81%
2024-09-30-42.76%
2024-06-30-41.13%
2024-03-31-44.25%
2023-12-31-39.40%
2023-09-30-35.30%
2023-06-30-30.07%
2023-03-31-26.95%
2022-12-31-23.10%
2022-09-30-33.65%
2022-06-30-28.94%
2022-03-31-25.59%
2021-12-31-22.22%
2021-09-30-19.85%
2021-06-30-17.32%
2021-03-31-14.89%
2020-12-31-13.44%
2020-09-30-22.14%
2020-06-30-18.39%
2020-03-31-22.48%
2019-12-31-17.37%
2019-09-30-23.10%
2019-06-30-21.11%
2019-03-31-19.98%
2018-12-31-20.39%
2018-09-30-18.01%
2018-06-30-43.69%
2018-03-31-29.80%

Annual ROA

DateROA
2026-03-31-94.45%
2025-03-31-44.85%
2024-03-31-44.25%
2023-03-31-26.95%
2022-03-31-25.59%
2021-03-31-14.89%
2020-03-31-22.48%
2019-03-31-19.98%
2018-03-31-30.24%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Vor Biopharma Inc. (VOR)United States$1.091B1.60
MeiraGTx Holdings plc (MGTX)United States$1.061B16.10
Monte Rosa Therapeutics, Inc. (GLUE)United States$1.002B-12.81
Cullinan Therapeutics, Inc. (CGEM)United States$0.993B-5.72
Odyssey Therapeutics, Inc. (ODTX)United States$0.960B
Maze Therapeutics, Inc. (MAZE)United States$1.457B-12.40
Inhibrx Biosciences, Inc. (INBX)United States$1.477B-10.08
Sana Biotechnology, Inc. (SANA)United States$0.886B-4.92
Candel Therapeutics, Inc. (CADL)United States$0.885B-8.86
Attovia Therapeutics, Inc. (ATTO)United States$0.828B